Cargando…

Correction: Epimorphin-Induced MET Sensitizes Ovarian Cancer Cells to Platinum

Detalles Bibliográficos
Autores principales:	Yew, Kok-Hooi, Crow, Jennifer, Hirst, Jeff, Pessetto, Ziyan, Godwin, Andrew K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810514/ http://dx.doi.org/10.1371/annotation/9c557fb1-7997-4c21-bd11-03bf5c3d4418

Ejemplares similares

Epimorphin-Induced MET Sensitizes Ovarian Cancer Cells to Platinum
por: Yew, Kok-Hooi, et al.
Publicado: (2013)

Epimorphin expression in interstitial pneumonia
por: Terasaki, Yasuhiro, et al.
Publicado: (2005)

Developing a genetic signature to predict drug response in ovarian cancer
por: Hyter, Stephen, et al.
Publicado: (2017)

Exosomes as mediators of platinum resistance in ovarian cancer
por: Crow, Jennifer, et al.
Publicado: (2017)

Epimorphin Functions as a Key Morphoregulator for Mammary Epithelial Cells
por: Hirai, Yohei, et al.
Publicado: (1998)

Correction: Rucaparib as a Salvage Treatment in Platinum-Sensitive Relapsed Ovarian Carcinoma: A Case Report
por: Biswas, Ghanashyam
Publicado: (2022)

Epimorphin Mediates Mammary Luminal Morphogenesis through Control of C/EBPβ
por: Hirai, Yohei, et al.
Publicado: (2001)

Autocrine Stimulation of Human Pancreatic Duct–Like Development by Soluble Isoforms of Epimorphin in Vitro
por: Lehnert, Lasse, et al.
Publicado: (2001)

Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
por: Wu, Huan, et al.
Publicado: (2020)

Epimorphin Alters the Inhibitory Effects of SOX9 on Mmp13 in Activated Hepatic Stellate Cells
por: Pritchett, James, et al.
Publicado: (2014)

Correction: Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer
por: Stefanou, Dimitra T., et al.
Publicado: (2021)

Correction: SERPINB3 in the Chicken Model of Ovarian Cancer: A Prognostic Factor for Platinum Resistance and Survival in Patients with Epithelial Ovarian Cancer
por: Lim, Whasun, et al.
Publicado: (2013)

Author Correction: CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity
por: Walton, Josephine B., et al.
Publicado: (2018)

Correction to: The efficacy and safety profile of 2-weekly dosing of bevacizumab-containing chemotherapy for platinum-resistant recurrent ovarian cancer
por: Sekine, Masayuki, et al.
Publicado: (2021)

Correction: Iron(III)-Salophene: An Organometallic Compound with Selective Cytotoxic and Anti-Proliferative Properties in Platinum-Resistant Ovarian Cancer Cells
por: Lange, Thilo S., et al.
Publicado: (2008)

Correction: hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of ‘MET-addicted’ cancers
por: Martinelli, Ilaria, et al.
Publicado: (2022)

Epimorphin Regulates Bile Duct Formation via Effects on Mitosis Orientation in Rat Liver Epithelial Stem-Like Cells
por: Zhou, Junnian, et al.
Publicado: (2010)

Correction for: circ5912 suppresses cancer progression via inducing MET in bladder cancer
por: Su, Yinjie, et al.
Publicado: (2020)

Publisher Correction: Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer
por: Qi, Ruogu, et al.
Publicado: (2018)

Author Correction: Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer
por: Qi, Ruogu, et al.
Publicado: (2020)

Correction: Influence of platinum harmonized textile on neuromuscular, systemic and subjective recovery
por: Zinke, Fridolin, et al.
Publicado: (2018)

Correction: NOXA-Induced Alterations in the Bax/Smac Axis Enhance Sensitivity of Ovarian Cancer Cells to Cisplatin
por: Lin, Chao, et al.
Publicado: (2012)

Correction to: Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy
por: Jiang, Wei, et al.
Publicado: (2022)

Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer
por: Della Pepa, Chiara, et al.
Publicado: (2014)

HIV and HCV Co-Culture Promotes Profibrogenic Gene Expression through an Epimorphin-Mediated ERK Signaling Pathway in Hepatic Stellate Cells
por: Shi, Lei, et al.
Publicado: (2016)

Correction: Constitutive BAK/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer
por: Liu, Dongyan, et al.
Publicado: (2021)

A Synthetic Lethality Screen Using a Focused siRNA Library to Identify Sensitizers to Dasatinib Therapy for the Treatment of Epithelial Ovarian Cancer
por: Pathak, Harsh B., et al.
Publicado: (2015)

PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
por: Morgan, Robert D., et al.
Publicado: (2018)

Correction to: Carbon Dots @ Platinum Porphyrin Composite as Theranostic Nanoagent for Efficient Photodynamic Cancer Therapy
por: Wu, Fengshou, et al.
Publicado: (2019)

Correction to: The genomic signature of resistance to platinum-containing neoadjuvant therapy based on single-cell data
por: Sui, Qihai, et al.
Publicado: (2023)

Markers of Oxidative Stress and Inflammation in Ascites and Plasma in Patients with Platinum-Sensitive, Platinum-Resistant, and Platinum-Refractory Epithelial Ovarian Cancer
por: Cantón-Romero, Juan Carlos, et al.
Publicado: (2017)

Nano pom-poms prepared exosomes enable highly specific cancer biomarker detection
por: He, Nan, et al.
Publicado: (2022)

Correction: Tamoxifen and Ovarian Function
por: Berliere, Martine, et al.
Publicado: (2013)

Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer [Corrigendum]
Publicado: (2014)

Platinum-Sensitive Recurrence in Ovarian Cancer: The Role of Tumor Microenvironment
por: Chien, Jeremy, et al.
Publicado: (2013)

Maintenance with Trabectedin in the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer
por: Guerra Alía, Eva María, et al.
Publicado: (2019)

Cholesterol Homeostasis Modulates Platinum Sensitivity in Human Ovarian Cancer
por: Criscuolo, Daniela, et al.
Publicado: (2020)

Effective Inhibition of c-MET-mediated Signaling, Growth, and Migration of Ovarian Cancer Cells is Influenced by the Ovarian Tissue Microenvironment
por: Kwon, Youngjoo, et al.
Publicado: (2013)

Correction to: A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients
por: Sun, Chaoyang, et al.
Publicado: (2020)

Author Correction: An integrated platinum-nanocarbon electrocatalyst for efficient oxygen reduction
por: Huang, Lei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6fq94s9p5ourketqc227ueom12